← back to search

Amitava Mitra

Kura Oncology (United States) · US
Area of research
Pharmaceutical Science · Molecular Biology
Research interest
Research interests include Drug Solubulity and Delivery Systems, Protein purification and stability, Pharmaceutical studies and practices, and Crystallization and Solubility Studies.
h-index
32
citations
2,872
works
72
NIH funding
primary concept
Medicine
email

Recent publications

Ziftomenib in Relapsed or Refractory <i>NPM1</i> -Mutated AML
Journal of Clinical Oncology 2025cited by 16position: middledoi
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
The Lancet Oncology 2024cited by 86position: middledoi
Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review
European Journal of Pharmaceutical Sciences 2021cited by 324position: middledoi
<i>In Silico</i> Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole
Molecular Pharmaceutics 2017cited by 73position: middledoi
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results
European Journal of Pharmaceutical Sciences 2016cited by 66position: middledoi
An In-Depth View into Human Intestinal Fluid Colloids: Intersubject Variability in Relation to Composition
Molecular Pharmaceutics 2016cited by 63position: middledoi
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes
European Journal of Pharmaceutical Sciences 2016cited by 45position: middledoi

Grants

Efficient Gene Silencing by Intrinsic Direct Repeats: Mechanism and Utilization
NSF0235302$390,0002003–2007PIRePORTER
Fungal Zoospore Mediated Transfer of Foreign DNA in Plants
NSF9206003$48,9771992–1994PIRePORTER

Frequent collaborators

Patrick Augustijns · KU Leuven3 papers (2016–2021)Joachim Brouwers · KU Leuven2 papers (2016–2017) · 1 papers (2021–2021)Bart Hens · KU Leuven1 papers (2017–2017)Masoud Jamei · University of Manchester1 papers (2017–2017)David B. Turner · Wright-Patterson Air Force Base1 papers (2017–2017)Dániel Keszthelyi · University of Oslo1 papers (2021–2021)Jef Stappaerts · KU Leuven1 papers (2021–2021) · 1 papers (2021–2021)Christos Reppas · National and Kapodistrian University of Athens1 papers (2021–2021)Danny Riethorst · KU Leuven1 papers (2016–2016)Tim Vanuytsel · VIB-KU Leuven Center for Microbiology1 papers (2021–2021) · 1 papers (2021–2021)Maria Vertzoni · National and Kapodistrian University of Athens1 papers (2021–2021)Maura Corsetti · Nottingham University Hospitals NHS Trust1 papers (2021–2021)Karel Allegaert · KU Leuven1 papers (2021–2021)Michael Grimm · Universitätsmedizin Greifswald1 papers (2021–2021)Nikunjkumar Patel · Brown University1 papers (2017–2017)Бо Лю · Walmart (United States)1 papers (2017–2017) · 1 papers (2021–2021)